Long-term management and results in heart transplant recipients

Cardiology Clinics

Volumn 8, Issue 1, 1990, Pages 141-148

  Valantine, H A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; OKT 3; PREDNISONE; THYMOCYTE ANTIBODY;

DRUG THERAPY; FOLLOW UP; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; RECIPIENT; SHORT SURVEY;

EID: 0025218771     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0733-8651(18)30389-8     Document Type: Short Survey

References (22)

1. Austen W.G. Cosimi A.B. Editorial retrospective: Heart transplantation after 16 years N Engl J Med 311 1984 1436
2. Billingham M.E. Diagnosis of rejection of endomyocardial biopsy J Heart Transplant 1 1982 25
3. Billingham M.E. Disease of the transplanted heart Symons C. Specific Heart Muscle Disease 1983 John Wright-Bon Bristol, UK 10 Chapter 12
4. Bristow MR, Gilbert EM, Renlund FH, and UTAH Cardiac Transplant Program OKT3 monoclonal antibody in cardiac transplantation: Antirejection treatment and retreatment and preliminary results in a prospectively randomized trial for prophylaxis. Transplant Proc, in press
5. Bristow M.R. Gilbert E.M. Renlund F.G. Use of OKT3 monoclonal antibody in heart transplantation: Review of the initial experience J Heart Transplant 7 1988 1
6. Caves P.K. Stinson E.B. Graham E.B. Percutaneous transvenous endomyocardial biopsy Am Med J 225 1973 288
7. Cosimi A.B. Burton R.C. Colvin R.B. Treatment of acute renal allograft rejection with OKT3 monoclonal antibody Transplantation 32 1981 535
8. Fieguth H.G. Haverich A. Schafers H.J. Cytoim-munologic monitoring in early and late acute cardiac rejection J Heart Transplant 7 1988 95
9. Fraser C.D. Chacko V.P. Mueller P. Early 31P NMR bioenergetic changes potentially predict rejection in heterotopic cardiac allografts J Heart Transplant 7 1988 118A
10. Gao S.Z. Schroeder J.S. Alderman E.L. Clinical and laboratory correlates of accelerated coronary artery disease in the cardiac transplant patient Circulation 76 1987 V-56
11. Gao S.Z. Schroeder J.S. Hunt S. Alderman E.L. Re-transplantation for severe accelerated coronary vascular disease in heart transplant recipients Am J Cardiol 62 1988 876 881
12. Gilbert E.M. Eiswirth C.C. Renlund D.G. OKT3 monoclonal antibody for early prophylaxis in cardiac transplantation J Am Coll Cardiol 9 1987 30A
13. Hunt S.A. Oyer P.E. Stinson E.B. Late postoperative management of cardiac transplant recipients Car-diovasc Rev Rep 4 1933 121
14. Hunt S.A. Stinson E.B. Cardiac transplantation Annu Rev Med 32 1981 213
15. Hunt S. Strober S. Hoppe R. Use of total lymphoid irradiation for therapy of intractable cardiac allograft rejection [abstract] J Heart Transplant 8 1989 104
16. Moran M. Tomlanovich S. Myers B.D. Cyclosporine-induced nephropathy in human recipients of cardiac allografts Transplant Proc 17 1985 185
17. Myers B.D. Ross J. Newton L. Cyclosporine-as-sociated chronic nephropathy N Engl J Med 311 1984 699
18. Oyer P.E. Stinson E.B. Jamieson S.Q. Cyclosporin-A in cardiac allografting: A preliminary experience Transplant Proc 15 1983 1247
19. Solis E. Kaye M.P. The Registry of International Society of Heart Transplantation: Third official report-June 1986 J Heart Transplant 5 1986 2
20. Sweeney M.S. Sinnott J.T. Cullison J.P. and the Cardiac Transplant Team The use of OKT3 for stubborn heart allograft rejection: An advance in clinical immunotherapy? J Heart Transplant 6 1987 324
21. Valantine H.A. Fowler M.B. Hunt S.A. Changes in Doppler echocardiographic indices of left ventricular function as potential markers of acute cardiac rejection Circulation 76 1987 V-86
22. Valantine H.A. Mullin A.V. Hunt S.A. Detection of accelerated graft atherosclerosis: Importance of hemodynamic response to exercise Circulation 78 II 1988 II-252